Inhibition of BUB1 Kinase by BAY 1816032 Sensitizes Tumor Cells Towards Taxanes, ATR and PARP Inhibitors in Vitro and in Vivo
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-0628
Full Text
Open PDFAbstract
Available in full text
Date
November 14, 2018
Authors
Publisher
American Association for Cancer Research (AACR)